1. de Boer, S. M., B. G. Wortman, T. Bosse, M. E. Powell, N. Singh, H. Hollema, G. Wilson, M. N. Chowdhury, L. Mileshkin, J. Pyman, D. Katsaros, S. Carinelli, A. Fyles, C. M. McLachlin, C. Haie-Meder, P. Duvillard, R. A. Nout, K. W. Verhoeven-Adema, H. Putter, C. L. Creutzberg, and Vthbm Smit. 2018. 'Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer', Ann Oncol, 29: 424-30.
  2. Friedlander, M., V. Gebski, E. Gibbs, L. Davies, R. Bloomfield, F. Hilpert, L. B. Wenzel, D. Eek, M. Rodrigues, A. Clamp, R. T. Penson, D. Provencher, J. Korach, T. Huzarski, L. Vidal, V. Salutari, C. Scott, M. O. Nicoletto, K. Tamura, D. Espinoza, F. Joly, and E. Pujade-Lauraine. 2018. 'Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial', Lancet Oncol, 19: 1126-34.
  3. Garsed, D. W., K. Alsop, S. Fereday, C. Emmanuel, C. J. Kennedy, D. Etemadmoghadam, B. Gao, V. Gebski, V. Gares, E. L. Christie, M. C. A. Wouters, K. Milne, J. George, A. M. Patch, J. Li, G. M. Arnau, T. Semple, S. R. Gadipally, Y. E. Chiew, J. Hendley, T. Mikeska, G. V. Zapparoli, K. Amarasinghe, S. M. Grimmond, J. V. Pearson, N. Waddell, J. Hung, C. J. R. Stewart, R. Sharma, P. E. Allan, P. F. Rambau, O. McNally, L. Mileshkin, A. Hamilton, S. Ananda, M. Grossi, P. A. Cohen, Y. C. Leung, R. M. Rome, P. Beale, P. Blomfield, M. Friedlander, A. Brand, A. Dobrovic, M. Kobel, P. Harnett, B. H. Nelson, D. D. L. Bowtell, and A. deFazio. 2018. 'Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer', Clin Cancer Res, 24: 569-80.
  4. Goergen, S. K., E. Posma, D. Wrede, J. Collett, J. Pyman, E. Alibrahim, J. Keene, and A. Dobrotwir. 2018. 'Interobserver agreement and diagnostic performance of individual MRI criteria for diagnosis of placental adhesion disorders', Clin Radiol, 73: 908 e1-08 e9.
  5. Hamilton, C. A., A. Miller, Y. Casablanca, N. S. Horowitz, B. Rungruang, T. C. Krivak, S. D. Richard, N. Rodriguez, M. J. Birrer, F. J. Backes, M. A. Geller, M. Quinn, M. J. Goodheart, D. G. Mutch, J. J. Kavanagh, G. L. Maxwell, and M. A. Bookman. 2018. 'Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study', Gynecol Oncol, 148: 275-80.
  6. Holland, C., A. Hocking, L. Joubert, F. McDermott, M. D. Niski, F. Thomson Salo, and M. A. Quinn. 2018. 'My Kite Will Fly: Improving Communication and Understanding in Young Children When a Mother Is Diagnosed with Life-Threatening Gynecological Cancer', J Palliat Med, 21: 78-84.
  7. Kampan, N. C., S. D. Xiang, O. M. McNally, A. N. Stephens, M. A. Quinn, and M. Plebanski. 2018. 'Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities', Curr Med Chem, 25: 4785-806.
  8. Kondrashova, O., M. Topp, K. Nesic, E. Lieschke, G. Y. Ho, M. I. Harrell, G. V. Zapparoli, A. Hadley, R. Holian, E. Boehm, V. Heong, E. Sanij, R. B. Pearson, J. J. Krais, N. Johnson, O. McNally, S. Ananda, K. Alsop, K. J. Hutt, S. H. Kaufmann, K. K. Lin, T. C. Harding, N. Traficante, A. deFazio, I. A. McNeish, D. D. Bowtell, E. M. Swisher, A. Dobrovic, M. J. Wakefield, and C. L. Scott. 2018. 'Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma', Nat Commun, 9: 3970.
  9. Lee, B., B. Tran, A. L. Hsu, G. R. Taylor, S. B. Fox, A. Fellowes, R. Marquis, J. Mooi, J. Desai, K. Doig, P. Ekert, C. Gaff, D. Herath, A. Hamilton, P. James, A. Roberts, R. Snyder, P. Waring, and G. McArthur. 2018. 'Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical setting', Intern Med J, 48: 786-94.
  10. Lin, M. Y., A. Dobrotwir, O. McNally, N. R. Abu-Rustum, and K. Narayan. 2018. 'Role of imaging in the routine management of endometrial cancer', Int J Gynaecol Obstet, 143 Suppl 2: 109-17.
  11. Saville, M., and O. McNally. 2018. ''Lest we forget' as we move forward with cervical screening', Aust N Z J Obstet Gynaecol, 58: 265-66

Share this page